Close search filters
Changing filters will change the listed Success Criteria and Techniques
Category
Topic
Search results (204)
Article
The benefits of timely and actionable specialty reporting
November 20, 2023
A comprehensive suite of reporting tools—and the right specialty partner to interpret data—can be invaluable for plan sponsors.
Newsroom
Express Scripts Will Unlock $20 Million in Savings for Clients in 2022 by Preferring the First Interchangeable Insulin Biosimilar
October 20, 2021
Article
The power of drug optimization
January 17, 2024
As plan sponsors consider impactful ways to manage spend in 2024 and beyond, the power of drug optimization should not be overlooked.
Article
Gene therapies: Million-dollar miracles
August 31, 2023
Gene therapies bring much-needed hope for treating rare conditions, but also concerns, especially around affordability. Learn about strategies plan sponsors can take to address these million-dollar me...
Article
Outcomes 2024: How Evernorth manages the drug pipeline today and prepares for tomorrow
May 08, 2024
Newsroom
Evernorth Continues Work to Reduce Costs and Improve Health With Expanded and Innovative Digital Health Formulary Platform
October 07, 2020
First-in-industry Digital Health Formulary is expanded to better enable people to find effective digital solutions that address their most pressing health care needs
Article
Most Favored Nation policy cannot succeed without the pharmacy benefit
May 20, 2025
Considering President Trump’s recent executive order, we examine the Most Favored Nation prescription drug pricing policy to the pharmacy benefit and discuss how removing PBMs – “the middleman” – is o...
Article
Enhancing recruitment for local clinical drug trials
January 16, 2024
During the panel, experts discussed ways they have navigated patient recruitment challenges.
Video
What are biosimilars?
October 17, 2022
To help clients prepare for the wave of biosimilars on the horizon, we answer some basic questions about these potentially game-changing medications.